Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 210

The DOI matches its Crossref record.

Thirty-Day Outcomes of Transcatheter Mitral Valve Replacement for Degenerated Mitral Bioprostheses (Valve-in-Valve), Failed Surgical Rings (Valve-in-Ring), and Native Valve With Severe Mitral Annular Calcification (Valve-in-Mitral Annular Calcification) in the United States: Data From the Society of Thoracic Surgeons/American College of Cardiology/Transcatheter Valve Therapy Registry

Open access
Guerrero, Mayra, Vemulapalli, Sreekanth, Xiang, Qun, Wang, Dee Dee, Eleid, Mackram, Cabalka, Allison K., Sandhu, Gurpreet, Salinger, Michael, Russell, Hyde, Greenbaum, Adam, Kodali, Susheel, George, Isaac, Dvir, Danny, Whisenant, Brian, Russo, Mark J., Pershad, Ashish, Fang, Kenith, Coylewright, Megan, Shah, Pinak, Babaliaros, Vasilis, Khan, Jaffar M., Tommaso, Carl, Saucedo, Jorge, Kar, Saibal, Makkar, Rajj, Mack, Michael, Holmes, David, Leon, Martin, Bapat, Vinayak, Thourani, Vinod H., Rihal, Charanjit, O’Neill, William, Feldman, Ted · 2020 · Circulation: Cardiovascular Interventions

Abstract

Background: Transcatheter mitral valve replacement using aortic transcatheter heart valves has recently become an alternative for patients with degenerated mitral bioprostheses, failed surgical repairs with annuloplasty rings or severe mitral annular calcification who are poor surgical candidates. Outcomes of these procedures are collected in the Society of Thoracic Surgeons/American College of Cardiology/Transcatheter Valve Therapy Registry. A comprehensive analysis of mitral valve-in-valve (MViV), mitral valve-in-ring (MViR), and valve-in-mitral annular calcification (ViMAC) outcomes has not been performed. We sought to evaluate short-term outcomes of early experience with MViV, MViR, and ViMAC in the United States. Methods: Retrospective analysis of data from the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry. Results: Nine hundred three high-risk patients (median Society of Thoracic Surgeons score 10%) underwent MViV (n=680), MViR (n=123), or ViMAC (n=100) between March 2013 and June 2017 at 172 hospitals. Median age was 75 years, 59.2% female. Technical and procedural success were higher in MViV. Left ventricular outflow tract obstruction occurred more frequently with ViMAC (ViMAC=10%, MViR=4.9%, MViV=0.7%; P <0.001). In-hospital mortality (MViV=6.3%, MViR=9%, ViMAC=18%; P =0.004) and 30-day mortality (MViV=8.1%, MViR=11.5%, ViMAC=21.8%; P =0.003) were higher in ViMAC. At 30-day follow-up, median mean mitral valve gradient was 7 mm Hg, most patients (96.7%) had mitral regurgitation grade ≤1 (+) and were in New York Heart Association class I to II (81.7%). Conclusions: MViV using aortic balloon-expandable transcatheter heart valves is associated with a low complication rate, a 30-day mortality lower than predicted by the Society of Thoracic Surgeons score, and superior short-term outcomes than MViR and ViMAC. At 30 days, patients in all groups experienced improvement of symptoms, and valve performance remained stable. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT02245763.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circinterventions.119.008425

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 210

Metadata

Authors
Guerrero, M., Vemulapalli, S., Xiang, Q., Wang, D. D., Eleid, M., Cabalka, A. K., Sandhu, G., Salinger, M., Russell, H., Greenbaum, A., Kodali, S., George, I., Dvir, D., Whisenant, B., Russo, M. J., Pershad, A., Fang, K., Coylewright, M., Shah, P., Babaliaros, V., Khan, J. M., Tommaso, C., Saucedo, J., Kar, S., Makkar, R., Mack, M., Holmes, D., Leon, M., Bapat, V., Thourani, V. H., Rihal, C., O’Neill, W., & Feldman, T.
Venue
Circulation: Cardiovascular Interventions
Published
2020-03
Volume
13
Issue
3
Pages
e008425-e008425
ISSN
  • 1941-7632 (ISSN-L)
  • 1941-7640
OpenAlex
W3009663857
Cited by
210
References
0
FWCI
19.97
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Thirty-Day Outcomes of Transcatheter Mitral Valve Replacement for Degenerated Mitral Bioprostheses (Valve-in-Valve), Failed Surgical Rings (Valve-in-Ring), and Native Valve With Severe Mitral Annular Calcification (Valve-in-Mitral Annular Calcification) in the United States: Data From the Society of Thoracic Surgeons/American College of Cardiology/Transcatheter Valve Therapy Registry. https://app.cochat.ai/papers/10.1161/circinterventions.119.008425
The paper
Guerrero, M., Vemulapalli, S., Xiang, Q., Wang, D. D., Eleid, M., Cabalka, A. K., Sandhu, G., Salinger, M., Russell, H., Greenbaum, A., Kodali, S., George, I., Dvir, D., Whisenant, B., Russo, M. J., Pershad, A., Fang, K., Coylewright, M., Shah, P., . . . Feldman, T. (2020). Thirty-Day Outcomes of Transcatheter Mitral Valve Replacement for Degenerated Mitral Bioprostheses (Valve-in-Valve), Failed Surgical Rings (Valve-in-Ring), and Native Valve With Severe Mitral Annular Calcification (Valve-in-Mitral Annular Calcification) in the United States: Data From the Society of Thoracic Surgeons/American College of Cardiology/Transcatheter Valve Therapy Registry. Circulation: Cardiovascular Interventions. https://doi.org/10.1161/circinterventions.119.008425

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.